A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

To assess the efficacy of LEE011 compared to placebo in patients with relapsed/refractory teratoma with recent progression

Kusajili – Clinical trials directory